Bisphosphonates (BPP)
Bisphosphonates (BPP)
Bisphosphonates (BPP) are a class of drugs widely used to prevent and treat bone loss by inhibiting osteoclast-mediated bone resorption. They are the most commonly prescribed medications for osteoporosis and are also used in other conditions characterized by increased bone fragility, such as Paget’s disease of bone, bone metastases, multiple myeloma, primary hyperparathyroidism, and osteogenesis imperfecta123678.
Mechanism of Action
- Bisphosphonates are structurally similar to pyrophosphate and have a high affinity for bone mineral, particularly at sites of active bone remodeling124.
- They bind to hydroxyapatite in bone and are ingested by osteoclasts during bone resorption.
- Inside osteoclasts, bisphosphonates disrupt essential cellular processes, leading to osteoclast apoptosis (cell death), thereby reducing bone resorption and turnover12467.
- There are two main classes:
Clinical Uses
- Osteoporosis: Prevention and treatment, especially in postmenopausal women and those on long-term corticosteroids125678.
- Paget’s disease of bone: Reduces abnormal bone turnover1678.
- Bone metastases and multiple myeloma: Reduces bone pain, risk of fractures, and hypercalcemia137.
- Other conditions: Osteogenesis imperfecta, fibrous dysplasia, and primary hyperparathyroidism12.
Administration
- Available in oral (e.g., alendronate, risedronate) and intravenous (e.g., zoledronate, ibandronate) forms78.
- Oral bisphosphonates are poorly absorbed and should be taken on an empty stomach with water, remaining upright for at least 30 minutes to reduce gastrointestinal side effects48.
Benefits
- Increase bone mineral density (BMD)
- Significantly reduce the risk of vertebral, hip, and other fractures in osteoporosis12568
- Provide long-term skeletal protection, with benefits persisting even after treatment discontinuation8
Risks and Side Effects
- Common: Gastrointestinal upset (oral forms), flu-like symptoms (IV forms), bone/joint pain, fatigue348
- Rare but serious: Osteonecrosis of the jaw (ONJ), atypical femoral fractures, hypocalcemia, kidney dysfunction (especially with IV use)2358
- Prolonged use may be associated with low bone turnover and rare pathologic fractures25
- Regular review and possible “drug holidays” are recommended after 3–5 years of therapy to minimize long-term risks8
Summary Table
| Aspect | Details |
|---|---|
| Main action | Inhibit osteoclast-mediated bone resorption |
| Key uses | Osteoporosis, Paget’s disease, bone metastases, multiple myeloma, hypercalcemia |
| Administration | Oral or intravenous |
| Benefits | Increased BMD, reduced fracture risk |
| Common side effects | GI upset, bone/joint pain, flu-like symptoms |
| Serious risks | Osteonecrosis of jaw, atypical femoral fractures, hypocalcemia, renal issues |
Consult with Our Team of Experts Now!
At DrStemCellsThailand (DRSCT)‘s Anti-Aging and Regenerative Medicine Center of Thailand, we emphasize comprehensive evaluations and personalized treatment plans of Cellular Therapy and Stem Cells for managing various health conditions. If you have questions about Bisphosphonates or would like more information on our services, consult with our experts today!
Consult with Our Team of Experts Now!
References
- Bisphosphonate – Wikipedia
- Bisphosphonates: Mechanism of Action and Role in Clinical Practice – PMC
- Bisphosphonates | Canadian Cancer Society
- Bisphosphonates: From Pharmacology to Treatment
- Long-term consequences of osteoporosis therapy with bisphosphonates – PubMed
- Bisphosphonates in the treatment of metabolic bone diseases
- Bisphosphonates: use and safety – GOV.UK
- Bisphosphonates | Versus Arthritis
In summary:
Bisphosphonates are potent antiresorptive agents that improve bone strength and reduce fracture risk in osteoporosis and other bone diseases by selectively inhibiting osteoclast activity. Their long-term use is generally safe and effective, though rare but serious side effects warrant periodic reassessment of therapy.
